226 patents currently held
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
60 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
48
Ending by 2030
Nov 2026
Next term end
126
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2031 · High confidence
Also notable
Ends Jun 2031 · High confidence
Also notable
Ends May 2030 · High confidence
Obstructive Sleep Apnea Treatment Devices, Systems and Methods
US 9,913,982
Cited by 176 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Method, Apparatus and System for Bipolar Charge Utilization During Stimulation by an Implantable Medical Device
US 8,260,426
Cited by 128 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity
US 8,600,521
Cited by 296 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 6 to 18, 2026 · next Dec 6
- 3 fees due Jan 4 to 28, 2027 · next Jan 4
- 4 fees due Feb 20 to 28, 2027 · next Feb 20
- 5 fees due Mar 5 to 17, 2027 · next Mar 5
- 8 fees due Apr 1 to 24, 2027 · next Apr 1
- 3 fees due May 5 to 21, 2027 · next May 5
- 4 fees due Jun 8 to 29, 2027 · next Jun 8
- 6 fees due Jul 9 to 26, 2027 · next Jul 9
- 3 fees due Aug 16 to 23, 2027 · next Aug 16
- 5 fees due Sep 1 to 19, 2027 · next Sep 1
- 3 fees due Oct 5 to 28, 2027 · next Oct 5
- 2 fees due Nov 12 to 14, 2027 · next Nov 12
Recent changes
- 4 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 126 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Obstructive Sleep Apnea Treatment Devices, Systems and Methods | 18 in force | to Dec 2032 |
| Far Field Radiative Powering of Implantable Medical Therapy Delivery Devices | 7 in force | to Feb 2035 |
| Responsive Neurostimulation for the Treatment of Chronic Cardiac Dysfunction | 6 in force | to Nov 2035 |
| Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction | 5 in force | to Aug 2034 |
| Algorithm for Detecting a Seizure from Cardiac Data | 5 in force | to Nov 2031 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,835,796 | Weight Loss Method and Device In force · High confidence | In force | High confidence | |
| US 7,532,935 | Selective Neurostimulation for Treating Mood Disorders In force · Medium confidence | In force | Medium confidence | |
| US 8,165,693 | Safe-Mode Implantable Medical Devices In force · High confidence | In force | High confidence | |
| US 7,620,455 | Cranial Nerve Stimulation to Treat Eating Disorders In force · High confidence | In force | High confidence | |
| US 7,499,752 | Selective Nerve Stimulation for the Treatment of Eating Disorders In force · High confidence | In force | High confidence | |
| US 8,306,627 | Dosing Limitation for an Implantable Medical Device In force · High confidence | In force | High confidence | |
| US 7,555,344 | Selective Neurostimulation for Treating Epilepsy In force · High confidence | In force | High confidence | |
| US 7,711,419 | Neurostimulator with Reduced Size In force · High confidence | In force | High confidence | |
| US 9,480,845 | Nerve Stimulation Device with a Wearable Loop Antenna In force · High confidence | In force | High confidence | |
| US 7,489,561 | Implantable Medical Device with Reconfigurable Non-Volatile Program In force · High confidence | In force | High confidence |
Also on record, not counted in the 226: 5 patents in force now held by others · 69 patents ended · 35 applications pending · 45 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.